an uptick in use of GLP-1 drugs suppressing consumption or other “potential regulatory changes,” such as state or federal bans on specific food additives, executives brashly declared yesterday.

Before that (pictured left in 2020), nutrition and exercise alone didn't work and she developed high blood pressure ... lifestyle changes. She argues that health insurers will still incur costs in the ...

Their findings published in Nature Medicine on Monday suggest that GLP-1 use is linked to beneficial ... Meanwhile, gastrointestinal disorders, low blood pressure, arthritis, and pancreatitis ...

However, many health outcomes, like nausea and vomiting, saw their risks increase with GLP-1 use. Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of ...

A new study suggests that weight loss and diabetes treatment may represent only a small sample of the potential uses of GLP-1 drugs.